Form 4 for YARW Yarrow Bioscience, Inc.
Accepted 2026-07-02 20:05:04 ET · period of report 2026-06-30 · accession 0001727794-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 20:05 | 2026-06-30 | YARW | Domzalski David | Pres AND CEO, Dir | F - Tax | $0.6507 | -12.2K | 426.6K | -3% | -$7,948 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-30 | F | D | 12,214 | $0.6507 | 426,565 | D | — | — | (F1) Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |